Tessa J. De Bitter

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics.

Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics.

Journal: The New England journal of medicine
Published: June 15, 2026

Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Journal: Scientific reports
Published: July 10, 2025

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2025

Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands.

Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands.

Journal: Scientific reports
Published: January 20, 2025

Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.

Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.

Journal: Oral oncology
Published: October 30, 2023

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Journal: Cancers
Published: October 27, 2022

Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5).

Journal: Scientific reports
Published: September 16, 2022

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.

Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020.

Journal: Frontiers in oncology
Published: May 25, 2022

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Journal: NPJ precision oncology
Published: May 17, 2022

Metastasis in the gallbladder: does literature reflect reality?

Metastasis in the gallbladder: does literature reflect reality?

Journal: Virchows Archiv : an international journal of pathology
Published: September 22, 2021

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications.

Journal: Cancers
Published: September 21, 2021

Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer.

Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer.

Journal: Annals of surgery
Published: August 13, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026